OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner
Charles Shing Kam, Daniel Wai‐Hung Ho, Vanessa Sheung‐In Ming, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 6, pp. 1325-1350
Open Access | Times Cited: 11
Charles Shing Kam, Daniel Wai‐Hung Ho, Vanessa Sheung‐In Ming, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 6, pp. 1325-1350
Open Access | Times Cited: 11
Showing 11 citing articles:
The Pentose Phosphate Pathway: From Mechanisms to Implications for Gastrointestinal Cancers
Jincheng Qiao, Zhiqing Yu, Han Zhou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 610-610
Open Access | Times Cited: 2
Jincheng Qiao, Zhiqing Yu, Han Zhou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 610-610
Open Access | Times Cited: 2
Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma
Qingyang Zhang, Yu‐Man Tsui, Xin Zhang, et al.
Theranostics (2024) Vol. 14, Iss. 2, pp. 892-910
Open Access | Times Cited: 16
Qingyang Zhang, Yu‐Man Tsui, Xin Zhang, et al.
Theranostics (2024) Vol. 14, Iss. 2, pp. 892-910
Open Access | Times Cited: 16
Metabolomic biomarkers in liquid biopsy: accurate cancer diagnosis and prognosis monitoring
Wenqian Wang, Shan-Shan Zhen, Ping Yu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 11
Wenqian Wang, Shan-Shan Zhen, Ping Yu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 11
Metabolic reprogramming of glucose: the metabolic basis for the occurrence and development of hepatocellular carcinoma
Kai Wang, Xiaodan Li, Shuwei Guo, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Kai Wang, Xiaodan Li, Shuwei Guo, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance
Jinfeng Wang, Jianfei Shi, Lili Mi, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Jinfeng Wang, Jianfei Shi, Lili Mi, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Glycolytic enzyme PFKFB4 governs lipolysis by promoting de novo lipogenesis to drive the progression of hepatocellular carcinoma
Shuo Zhou, Yao Liu, Ning Zhang, et al.
Cancer Letters (2025), pp. 217774-217774
Closed Access
Shuo Zhou, Yao Liu, Ning Zhang, et al.
Cancer Letters (2025), pp. 217774-217774
Closed Access
Fibrillarin Reprograms Glucose Metabolism by Driving the Enhancer-Mediated Transcription of PFKFB4 in Liver Cancer
Yizhe Liu, Qili Shi, Yanfang Liu, et al.
Cancer Letters (2024) Vol. 602, pp. 217190-217190
Open Access | Times Cited: 1
Yizhe Liu, Qili Shi, Yanfang Liu, et al.
Cancer Letters (2024) Vol. 602, pp. 217190-217190
Open Access | Times Cited: 1
PFKFB4 Is a Metabolic Driver of HCC Progression and Chemoresistance Through ROS Mitigation
Paula Olaizola, Jesús M. Bañales
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 6, pp. 1527-1529
Open Access | Times Cited: 3
Paula Olaizola, Jesús M. Bañales
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 6, pp. 1527-1529
Open Access | Times Cited: 3
A Lactic Acid Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironmental Status in Patients with Hepatocellular Carcinoma
Zhongcheng Zhou, Bin Wu, Jing Chen, et al.
Nutrition and Cancer (2024) Vol. 76, Iss. 3, pp. 279-295
Closed Access
Zhongcheng Zhou, Bin Wu, Jing Chen, et al.
Nutrition and Cancer (2024) Vol. 76, Iss. 3, pp. 279-295
Closed Access
Development and Validation of a Carbohydrate Metabolism-Related Model for Predicting Prognosis and Immune Landscape in Hepatocellular Carcinoma Patients
Hongxiang Huang, Peiyuan Zhong, Ping Li, et al.
Current Medical Science (2024) Vol. 44, Iss. 4, pp. 771-788
Closed Access
Hongxiang Huang, Peiyuan Zhong, Ping Li, et al.
Current Medical Science (2024) Vol. 44, Iss. 4, pp. 771-788
Closed Access
Expression and prognostic analysis of PFKFB4 in oral squamous cell carcinoma
Shuting Chen, Jiusong Han, Wei Wang, et al.
Cellular and Molecular Biology (2024) Vol. 70, Iss. 7, pp. 193-199
Closed Access
Shuting Chen, Jiusong Han, Wei Wang, et al.
Cellular and Molecular Biology (2024) Vol. 70, Iss. 7, pp. 193-199
Closed Access
REPROGRAMMING OF GLUCOSE METABOLISM FOR REVISITING HEPATOCELLULAR CARCINOMA RESISTANCE TO TRANSCATHETER HEPATIC ARTERIAL CHEMOEMBOLIZATION
Ruijie Zhang, Fan Dai, Shan Deng, et al.
ChemBioChem (2024) Vol. 26, Iss. 1
Open Access
Ruijie Zhang, Fan Dai, Shan Deng, et al.
ChemBioChem (2024) Vol. 26, Iss. 1
Open Access
